A Novel KCNA1 Mutation Associated with Global Delay and Persistent Cerebellar Dysfunction

被引:38
作者
Demos, Michelle K. [1 ]
Macri, Vincenzo [2 ]
Farrell, Kevin [1 ]
Nelson, Tanya N. [3 ]
Chapman, Kristine [4 ]
Accili, Eric [2 ]
Armstrong, Linlea [5 ]
机构
[1] British Columbia Childrens Hosp, Dept Pediat Neurol, Vancouver, BC V6H 3V4, Canada
[2] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada
[3] Childrens & Womens Hlth Ctr British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[4] Vancouver Hosp, Neuromuscular Dis Unit, Div Neurol, Vancouver, BC, Canada
[5] Childrens & Womens Hlth Ctr British Columbia, Dept Med Genet, Vancouver, BC, Canada
关键词
KCNA1; EA1; cerebellar atrophy; cognitive dysfunction; EPISODIC ATAXIA TYPE-1; POTASSIUM CHANNEL GENE; MYOKYMIA; PHENYTOIN; EPILEPSY;
D O I
10.1002/mds.22467
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Episodic Ataxia Type 1 is an autosomal dominant disorder characterized by episodes of ataxia and myokymia. It is associated with mutations in the KCNA1 voltage-gated potassium channel gene. In the present study, we describe a family with novel clinical features including persistent cerebellar dysfunction, cerebellar atrophy, and cognitive delay. All affected family members have myokymia and epilepsy, but only one individual has episodes of vertigo. Additional features include postural abnormalities, episodic stiffness and weakness. A novel KCNA1 mutation (c.1222G>T) which replaces a highly conserved valine with leucine at position 408 (p.Val408Leu) was identified in affected family members, and was found to augment the ability of the channel to inactivate. Together, our data suggest that KCNA1 mutations are associated with a broader clinical phenotype, which may include persistent cerebellar dysfunction and cognitive delay. (C) 2009 Movement Disorder Society
引用
收藏
页码:778 / 782
页数:5
相关论文
共 20 条
  • [1] Episodic ataxia results from voltage-dependent potassium channels with altered functions
    Adelman, JP
    Bond, CT
    Pessia, M
    Maylie, J
    [J]. NEURON, 1995, 15 (06) : 1449 - 1454
  • [2] EPISODIC ATAXIA MYOKYMIA SYNDROME IS ASSOCIATED WITH POINT MUTATIONS IN THE HUMAN POTASSIUM CHANNEL GENE, KCNA1
    BROWNE, DL
    GANCHER, ST
    NUTT, JG
    BRUNT, ERP
    SMITH, EA
    KRAMER, P
    LITT, M
    [J]. NATURE GENETICS, 1994, 8 (02) : 136 - 140
  • [3] FAMILIAL PAROXYSMAL KINESIGENIC ATAXIA AND CONTINUOUS MYOKYMIA
    BRUNT, ERP
    VANWEERDEN, TW
    [J]. BRAIN, 1990, 113 : 1361 - 1382
  • [4] Cancer research funding in Asia
    Cheng, Margaret Harris
    [J]. MOLECULAR ONCOLOGY, 2007, 1 (02): : 135 - 137
  • [5] Cerebellar volume and long-term use of phenytoin
    De Marco, FA
    Ghizoni, E
    Kobayashi, E
    Li, LM
    Cendes, F
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2003, 12 (05): : 312 - 315
  • [6] Eunson LH, 2000, ANN NEUROL, V48, P647
  • [7] Clinical features of a large Australian pedigree with episodic ataxia type 1
    Hand, PJ
    Gardner, RJM
    Knight, MA
    Forrest, SM
    Storey, E
    [J]. MOVEMENT DISORDERS, 2001, 16 (05) : 938 - 939
  • [8] CONTRACTURES, CONTINUOUS MUSCLE DISCHARGES, AND TITUBATION
    HANSON, PA
    MARTINEZ, LB
    CASSIDY, R
    [J]. ANNALS OF NEUROLOGY, 1977, 1 (02) : 120 - 124
  • [9] Primary episodic ataxias: diagnosis, pathogenesis and treatment
    Jen, J. C.
    Graves, T. D.
    Hess, E. J.
    Hanna, M. G.
    Griggs, R. C.
    Baloh, R. W.
    [J]. BRAIN, 2007, 130 : 2484 - 2493
  • [10] Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia
    Kinali, M
    Jungbluth, H
    Eunson, LH
    Sewry, CA
    Manzur, AY
    Mercuri, E
    Hanna, MG
    Muntoni, F
    [J]. NEUROMUSCULAR DISORDERS, 2004, 14 (10) : 689 - 693